0001493152-23-024750.txt : 20230717
0001493152-23-024750.hdr.sgml : 20230717
20230717170507
ACCESSION NUMBER: 0001493152-23-024750
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230713
FILED AS OF DATE: 20230717
DATE AS OF CHANGE: 20230717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elmaliah Oren
CENTRAL INDEX KEY: 0001713701
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37370
FILM NUMBER: 231092268
MAIL ADDRESS:
STREET 1: 3 ARAVA ST., POB 1206
CITY: AIRPORT CITY
STATE: L3
ZIP: 7010000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: My Size, Inc.
CENTRAL INDEX KEY: 0001211805
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: HAYARDEN 4
CITY: AIRPORT CITY
STATE: L3
ZIP: 7010000
BUSINESS PHONE: 972-36009030
MAIL ADDRESS:
STREET 1: HAYARDEN 4
CITY: AIRPORT CITY
STATE: L3
ZIP: 7010000
FORMER COMPANY:
FORMER CONFORMED NAME: Mysize Inc.
DATE OF NAME CHANGE: 20150317
FORMER COMPANY:
FORMER CONFORMED NAME: TOPSPIN MEDICAL INC
DATE OF NAME CHANGE: 20021226
4
1
ownership.xml
X0508
4
2023-07-13
0
0001211805
My Size, Inc.
MYSZ
0001713701
Elmaliah Oren
HAYARDEN 4
AIRPORT CITY
L3
7010000
ISRAEL
1
0
0
0
0
Option to purchase Common Stock (right to buy)
26.00
2023-07-13
4
D
0
1200
D
2025-08-10
Common Stock, $.001 par value per share
1200
0
D
Option to purchase Common Stock (right to buy)
1.09
2023-07-13
4
A
0
1200
A
2025-08-10
Common Stock, $.001 par value per share
1200
1200
D
Option to purchase Common Stock (right to buy)
26.00
2023-07-13
4
D
0
40
D
2024-05-29
Common Stock, $.001 par value per share
40
0
D
Option to purchase Common Stock (right to buy)
1.09
2023-07-13
4
A
0
40
A
2024-05-29
Common Stock, $.001 par value per share
40
40
D
Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.
Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged.
On December 8, 2022, the Company implemented a 1-for-25 reverse stock split (the "Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the Reverse Stock Split.
/s/ Oren Elmaliah
2023-07-17